Successful treatment of severe baclofen toxicosis initially refractory to conventional treatment

After ingesting a dose of baclofen thought to be lethal, a patient with severe neurologic signs was successfully managed despite initially being refractory to treatment. Patients with persistent neurologic abnormalities may still have an excellent prognosis despite lack of initial response. Addition...

Descripción completa

Detalles Bibliográficos
Autores principales: Fox, Christine M., Daly, Meredith L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5224782/
https://www.ncbi.nlm.nih.gov/pubmed/28096989
http://dx.doi.org/10.1002/ccr3.736
_version_ 1782493420164481024
author Fox, Christine M.
Daly, Meredith L.
author_facet Fox, Christine M.
Daly, Meredith L.
author_sort Fox, Christine M.
collection PubMed
description After ingesting a dose of baclofen thought to be lethal, a patient with severe neurologic signs was successfully managed despite initially being refractory to treatment. Patients with persistent neurologic abnormalities may still have an excellent prognosis despite lack of initial response. Additionally, we present a potential case of benzodiazepine withdrawal.
format Online
Article
Text
id pubmed-5224782
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-52247822017-01-17 Successful treatment of severe baclofen toxicosis initially refractory to conventional treatment Fox, Christine M. Daly, Meredith L. Clin Case Rep Case Reports After ingesting a dose of baclofen thought to be lethal, a patient with severe neurologic signs was successfully managed despite initially being refractory to treatment. Patients with persistent neurologic abnormalities may still have an excellent prognosis despite lack of initial response. Additionally, we present a potential case of benzodiazepine withdrawal. John Wiley and Sons Inc. 2016-12-20 /pmc/articles/PMC5224782/ /pubmed/28096989 http://dx.doi.org/10.1002/ccr3.736 Text en © 2016 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial‐NoDerivs (http://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Case Reports
Fox, Christine M.
Daly, Meredith L.
Successful treatment of severe baclofen toxicosis initially refractory to conventional treatment
title Successful treatment of severe baclofen toxicosis initially refractory to conventional treatment
title_full Successful treatment of severe baclofen toxicosis initially refractory to conventional treatment
title_fullStr Successful treatment of severe baclofen toxicosis initially refractory to conventional treatment
title_full_unstemmed Successful treatment of severe baclofen toxicosis initially refractory to conventional treatment
title_short Successful treatment of severe baclofen toxicosis initially refractory to conventional treatment
title_sort successful treatment of severe baclofen toxicosis initially refractory to conventional treatment
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5224782/
https://www.ncbi.nlm.nih.gov/pubmed/28096989
http://dx.doi.org/10.1002/ccr3.736
work_keys_str_mv AT foxchristinem successfultreatmentofseverebaclofentoxicosisinitiallyrefractorytoconventionaltreatment
AT dalymeredithl successfultreatmentofseverebaclofentoxicosisinitiallyrefractorytoconventionaltreatment

Ejemplares similares